Göm menyn

Publications for Daniel Öhman

Co-author map based on Web of Sciences articles 2007-

Journal Articles

Daniel Öhman, Maria Dolores Cherma Yeste, Björn Norlander and Finn Bengtsson
  Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetine
  Therapeutic Drug Monitoring, 2003, 25(2), 174-182.
 Web of Science® Times Cited: 19

Daniel Öhman, Björn Norlander, Curt Peterson and Finn Bengtsson
  Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatography
  Journal of Chromatography A, 2002, 947(2), 247-254.
 Web of Science® Times Cited: 23

Daniel Öhman, Björn Norlander, Curt Peterson and Finn Bengtsson
  Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC
  Therapeutic Drug Monitoring, 2001, 23(1), 27-34.
 Web of Science® Times Cited: 27

Daniel Öhman, Björn Norlander and Björn Carlsson
  On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma: results compared with solid-phase extraction methodology
  Journal of Chromatography B: Biomedical Sciences and Applications, 2001, 753(2), 365-373.
 Web of Science® Times Cited: 41

Love Linner, Hanna Endersz, Daniel Öhman, Finn Bengtsson, Martin Schalling and Torgny Svensson
  Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex
  Journal of Pharmacology and Experimental Therapeutics, 2001, 297(2), 540-546.
 Web of Science® Times Cited: 90

Conference Articles

Daniel Öhman, Curt Peterson and Finn Bengtsson
  Development of a TDM-Method for determination of the neuroleptic compound Ziprasidone and its S-methylated main metabolite.
  Pharmacol Toxicol,2001, 2001.

Ph.D. Theses

Daniel Öhman
  Bioanalytical development for application in therapeutic drug monitoring: focus on drugs used in psychiatry


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21